4.8 Article

Notch transactivates Rheb to maintain the multipotency of TSC-null cells

Journal

NATURE COMMUNICATIONS
Volume 8, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-017-01845-1

Keywords

-

Funding

  1. Developmental Corporation of Abilene
  2. NIH [2 U42 OD011158]
  3. National Institute of Health [R01CA190209]
  4. National Science Fundation [1052039]
  5. Cancer Prevention and Research Institute of Texas [RP120168]
  6. U.S. Department of Defense [TS140010]
  7. Laura W. Bush Institute for Women's Health
  8. Div Of Molecular and Cellular Bioscience
  9. Direct For Biological Sciences [1052039] Funding Source: National Science Foundation

Ask authors/readers for more resources

Differentiation abnormalities are a hallmark of tuberous sclerosis complex (TSC) manifestations; however, the genesis of these abnormalities remains unclear. Here we report on mechanisms controlling the multi-lineage, early neuronal progenitor and neural stem-like cell characteristics of lymphangioleiomyomatosis (LAM) and angiomyolipoma cells. These mechanisms include the activation of a previously unreported Rheb-Notch-Rheb regulatory loop, in which the cyclic binding of Notch1 to the Notch-responsive elements (NREs) on the Rheb promoter is a key event. This binding induces the transactivation of Rheb. The identified NRE2 and NRE3 on the Rheb promoter are important to Notch-dependent promoter activity. Notch cooperates with Rheb to block cell differentiation via similar mechanisms in mouse models of TSC. Cell-specific loss of Tsc1 within nestin-expressing cells in adult mice leads to the formation of kidney cysts, renal intraepithelial neoplasia, and invasive papillary renal carcinoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available